Announcements Trials
Browse Landscape

Status

Completed 2

Sponsor Class

OTHER 2INDUSTRY 2NIH 1

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

Genitourinary 1

Conditions

Diabetes Mellitus 2Urinary Bladder Neoplasms 1Neoplasms 1

Interventions

Blood Specimen Collection 31Sorafenib 29Nivolumab 29Bevacizumab 26Data Collection 24Observation 23palbociclib 22Sunitinib 22radium Ra 223 dichloride 20enzalutamide 18Rituximab 18Ipilimumab 16regorafenib 15Drug Therapy 15Trastuzumab 14Docetaxel 14ribociclib 12exemestane 12atezolizumab 12Standard of Care 12darolutamide 11apalutamide 11Leuprolide 11Capecitabine 11Afatinib 11Bortezomib 10Anastrozole 10trastuzumab deruxtecan 9pembrolizumab 9avelumab 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Observational × Pioglitazone × Clear all
NCT01637935 2018-03-07

Cohort Study of Pioglitazone and Bladder Cancer in Patients With Type II Diabetes

Takeda

Completed
193,099 enrolled 15 charts
Genitourinary

Urinary Bladder Neoplasms, Diabetes Mellitus

NCT02958956 2018-03-07

Cohort Study of Pioglitazone and Cancer Incidence in Participants With Diabetes Mellitus.

Takeda

Completed
236,507 enrolled 13 charts

Diabetes Mellitus, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡